Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
Zurich, Switzerland
Prof. Dr. Oliver Distler is Professor of Rheumatology at the University of Zurich and Head of the Department of Rheumatology at University Hospital Zurich in Switzerland. He is aldo heading the Center of Expertimental Rheumatology of the University of Zurich.
Prof. Dr. Distler earned his medical degree from the University of Erlangen in Germany in 1997. Subsequently, he completed his internship in internal medicine at Bamberg Hospital and his residency and fellowship at the University Hospital of Regensburg, both in Germany. Prof. Dr. Distler then did a postdoctoral fellowship in the Center of Experimental Rheumatology at the University of Zurich and additional fellowships in the Departments of Rheumatology and Clinical Immunology at University Hospital Zurich.
Prof. Dr. Distler’s research focuses on molecular mechanisms of inflammatory rheumatic diseases, the validation of biomarkers, the identification and characterization of animal models, and the design of proof-of-concept and phase 2/3 trials. He has authored over 500 papers on these topics, and he is a member of the editorial boards of Lancet Rheumatology and Annals of the Rheumatic Diseases.
Professor Distler is on the Board of Directors for several scientific organizations and initiatives in systemic sclerosis. He is currently Executive Chair of the EULAR-associated FOREUM Foundation.
Saturday, November 16, 2024
10:30 AM – 12:30 PM Eastern Time
No financial relationships with ineligible companies to disclose
MCTD Is a Unique Rheumatic Disease - Rebuttal
Sunday, November 17, 2024
4:00 PM – 4:10 PM Eastern Time
No financial relationships with ineligible companies to disclose
Sunday, November 17, 2024
4:20 PM – 4:30 PM Eastern Time
Disclosure(s): 4P-Pharma: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AbbVie: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Acceleron: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Alcimed: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AnaMar: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Argenx: Consultant (Ongoing); Arxx: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Blade Therapeutics: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cantargia AB: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Citus AG: Co-Founder (Ongoing); Corbus Pharmaceuticals: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CSL Behring: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Enzyvant: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Galapagos: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Galderma: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Glenmark: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gossamer: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Kymera: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lupin: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medscape: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck/MSD: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Miltenyi Biotec: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Mitsubishi Tanabe: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Nkarta: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Orion: Consultant (Ongoing); Patent issued “mir-29 for the treatment of systemic sclerosis” (US8247389, EP2331143): Intellectual Property/Patents (Ongoing); Prometheus Biosciences: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Redx Pharma: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Roivant: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Serono RD: Consultant (Ongoing); Topadur: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)